Get started
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITEDMEDICAL DEVELOPMENTS INTERNATIONAL LIMITEDMEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

MVP chart


Full chart

MVP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪44.50 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.465 AUD
Net income (FY)
‪−40.99 M‬ AUD
Revenue (FY)
‪33.15 M‬ AUD
Shares float
‪93.33 M‬
Beta (1Y)
−0.82

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED


Sector
Health Technology
CEO
Brent MacGregor
Headquarters
Scoresby
Website
medicaldev.com
Founded
2003
ISIN
AU000000MVP2
FIGI
BBG000CPBJ97
Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. It operates through the following segments: Pharmaceuticals, Medical Equipment, and Veterinary Equipment. The Pharmaceuticals segment involves the selling of Penthrox drugs. The Medical Equipment segment includes the sale of medical devices. The Veterinary Equipment segment relates to the sale of veterinary products within Australia, Europe, and Asia. The company was founded in 1971 and is headquartered in Scoresby, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MVP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MVP is 0.405 AUD — it has increased by 2.53% in the past 24 hours. Watch MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stocks are traded under the ticker MVP.
MVP stock hasn't changed in a week, the month change is a −4.71% fall, over the last year MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED has showed a −46.02% decrease.
We've gathered analysts' opinions on MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED future price: according to them, MVP price has a max estimate of 2.94 AUD and a min estimate of 2.94 AUD. Watch MVP chart and read a more detailed MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock forecast: see what analysts think of MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED and suggest that you do with its stocks.
MVP reached its all-time high on Feb 20, 2020 with the price of 11.630 AUD, and its all-time low was 0.140 AUD and was reached on Jun 29, 2009. View more price dynamics on MVP chart.
See other stocks reaching their highest and lowest prices.
MVP stock is 2.53% volatile and has beta coefficient of −0.82. Track MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED there?
Today MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED has the market capitalization of ‪45.63 M‬, it has decreased by −2.41% over the last week.
Yes, you can track MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED financials in yearly and quarterly reports right on TradingView.
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MVP earnings for the last half-year are −0.35 AUD per share, whereas the estimation was −0.20 AUD, resulting in a −71.43% surprise. The estimated earnings for the next half-year are −0.02 AUD per share. See more details about MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED earnings.
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED revenue for the last half-year amounts to ‪18.10 M‬ AUD, despite the estimated figure of ‪18.10 M‬ AUD. In the next half-year revenue is expected to reach ‪19.70 M‬ AUD.
MVP net income for the last half-year is ‪−30.05 M‬ AUD, while the previous report showed ‪−10.95 M‬ AUD of net income which accounts for −174.53% change. Track more MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED EBITDA is ‪−13.47 M‬ AUD, and current EBITDA margin is −40.64%. See more stats in MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED financial statements.
Like other stocks, MVP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock shows the sell signal. See more of MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.